Donor‐specific antibodies are associated with micro‐ and macrovascular coronary disease, restrictive myocardial damage, and poor outcome in heart‐transplanted patients

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

    loading  Loading Related Articles